$22.11
-2.00-8.27%
Last update: Nov 10, 2:35 PM
Bright Minds Biosciences Inc
DRUGNASDAQ
The average analyst price target for Bright Minds Biosciences is $121.13, 447.7% above the current price. Of 9 analysts, 9 rate it Buy. Targets range from $37 to $220. The latest change came on Nov 3, 2026, when Baird lowered its price target on Bright Minds Biosciences from $126 to $107 and kept an Outperform rating.
Price Target Range — 9 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months
